QQ客服 官方微博 反馈留言

	Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment
	Wu, Bo; Lu, Shu-Ting; Zhang, Liu-Jie; Zhuo, Ren-Xi; Xu, Hai-Bo; Huang, Shi-Wen
刊名	INTERNATIONAL JOURNAL OF NANOMEDICINE
	2017
卷号	12
关键词	triptolide codelivery reduction sensitive synergistic effect
ISSN号	1178-2013
DOI	10.2147/IJN.S131235
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4096148
专题	武汉大学
推荐引用方式 GB/T 7714	Wu, Bo,Lu, Shu-Ting,Zhang, Liu-Jie,et al. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment[J]. INTERNATIONAL JOURNAL OF NANOMEDICINE,2017,12.
APA	Wu, Bo,Lu, Shu-Ting,Zhang, Liu-Jie,Zhuo, Ren-Xi,Xu, Hai-Bo,&Huang, Shi-Wen.(2017).Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.INTERNATIONAL JOURNAL OF NANOMEDICINE,12.
MLA	Wu, Bo,et al."Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment".INTERNATIONAL JOURNAL OF NANOMEDICINE 12(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。